DA32 Life Science Tech Ac... (DALS)
DA32 Life Science Tech Acquisition Statistics
Share Statistics
DA32 Life Science Tech Acquisition has - shares outstanding. The number of shares has increased by null% in one year.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| 100 |
| 0.34% |
Short Selling Information
The latest short interest is 1.87K, so 0.01% of the outstanding shares have been sold short.
| 1.87K |
| 0.01% |
| 0.01% |
| 1 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for DA32 Life Science Tech Acquisition.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| null |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| undefined |
| n/a |
| n/a |
Taxes
| n/a |
| n/a |
Stock Price Statistics
The stock price has increased by -0.19% in the last 52 weeks. The beta is 0, so DA32 Life Science Tech Acquisition's price volatility has been lower than the market average.
| 0 |
| -0.19% |
| 10.25 |
| 10.07 |
| 64.15 |
| 29,061 |
Margins
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Dividends & Yields
DALS does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| n/a |
| n/a |